Gene diagnosis for nine Chinese patients with DMD/BMD by multiplex ligation-dependent probe amplification and prenatal diagnosis for one of them

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 6, 2009, Pages 380-386

  Wu, Yupeng ^a,b   Yin, Gengxin ^a,b   Fu, Keqin ^a   Wu, De ^c   Zhai, Qian ^a   Du, Huarong ^a   Huang, Zhongjun ^a   Niu, Yuhua ^a  

^a Anhui Research Institute for Family Planning   (China)

^b Anhui Research Center for the Quality of the Newborn Population   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Duchenne Becker muscular dystrophy; Gene diagnosis; Linkage analysis; MLPA; Prenatal diagnosis; STR genotyping

Indexed keywords

DYSTROPHIN; GENOMIC DNA;

ADOLESCENT; ARTICLE; CHILD; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENOTYPE; HUMAN; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; SHORT TANDEM REPEAT; X CHROMOSOME; X CHROMOSOME LINKAGE;

AMNIOTIC FLUID; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; DYSTROPHIN; EXONS; FEMALE; FETUS; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; MICROSATELLITE REPEATS; MUSCULAR DYSTROPHY, DUCHENNE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PEDIGREE; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE DELETION;

EID: 73249137367     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20349     Document Type: Article

References (34)

1. van Essen AJ, Busch HF, te Meerman GJ, ten Kate LP. Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands. Hum Genet 1992;88:258-266.
2. Mostacciuolo ML, Lombardi A, Cambissa V, Danieli GA, Angelini C. Population data on benign and severe forms of X-linked muscular dystrophy. Hum Genet 1987;75:217-220.
3. Bushby KM, Thambyayah M, Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991;337:1022-1024.
4. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986;323:646-650.
5. Mandel JL. Dystrophin. The gene and its product. Nature 1989;339:584-586.
6. Den Dunnen JT, Grootscholten PM, Dauwerse JG, et al. Reconstruction of the 2.4Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet 1992;1:19-28.
7. Den Dunnen JT, Grootscholten PM, Bakker E, et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 1989;45:835-847.
8. Herczegfalvi A, Toth G, Gyurus P, et al. Deletion patterns of dystrophin gene in Hungarian patients with Duchenne/Becker muscular dystrophies. Neuromuscul Disord 1999;9:552-554.
9. Forrest SM, Cross GS, Speer A, Gardner-Medwin D, Burn J, Davies KE. Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature 1987;329:638-640.
10. Hu XY, Ray PN, Murphy EG, Thompson MW, Worton RG. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet 1990;46:682-695.
11. Roberts RG, Bobrow M, Bentley DR. Point mutations in the dystrophin gene. Proc Natl Acad Sci USA 1992;89:2331-2335.
12. Deburgrave N, Daoud F, Llense S, et al. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat 2007;28:183-195.
13. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45-48.
14. Traverso M, Malnati M, Minetti C, et al. Multiplex real-time PCR for detection of deletions and duplications in dystrophin gene. Biochemical Biophysical Research Communications 2006;339:145-150.
15. Fortina P, Cheng J, Shoffner MA, Surrey S, Hitchcock WM, Kricka LJ, Wilding P. Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis. Clin Chem 1997;43:745-751.
16. Velazquez-Wong AC, Hernandez-Huerta C, Marquez-Calixto A, Hernandez-Aguilar FO, Rodriguez-Cruz M, Salamanca-Gomez F, Coral-Vazquez R. Identification of duchenne muscular dystrophy female carriers by fluorescence in situ hybridization and RT-PCR. Genet Test 2008;12:221-223.
17. Rosenberg C, Navajas L, Vagenas DF, et al. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization. Neuromuscul Disord 1998;8:447-452.
18. Ligon AH, Kashork CD, Richards CS, Shaffer LG. Identification of female carriers for Duchenne and Becker muscular dystrophies using a FISH-based approach. Eur J Hum Genet 2000;8:293-298.
19. Bennett RR, den Dunnen J, O'Brien KF, Darras BT, Kunkel LM. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2001;2:17.
20. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic acids Res 2002;30:e57.
21. Soegaard M, Kjaer SK, Cox M, et al. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Clin Cancer Res 2008;14:3761-3767.
22. Lugtenberg D, Kleefstra T, Oudakker AR, et al. Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur J Hum Genet 2009;17:444-453.
23. Moelans CB, de Weger RA, van Blokland MT, Ezendam C, Elshof S, Tilanus MG, van Diest PJ. HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization. Cell Oncol 2009;31:1-10.
24. Clemens PR, Fenwick RG, Chamberlain JS, Gibbs RA, de Andrade M, Chakraborty R, Caskey CT. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet 1991;49:951-960.
25. Worton RG. Duchenne muscular dystrophy: Gene and gene product; mechanism of mutation in the gene. J Inherit Metab Dis 1992;15:539-550.
26. Jay V, Vajsar J. The dystrophy of Duchenne. Lancet 2001;357:550-552.
27. Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: Challenges, prospects and clinical trials. Trends Mol Med 2007;13:520-526.
28. Foster K, Foster H, Dickson JG. Gene therapy progress and prospects: Duchenne muscular dystrophy. Gene ther 2006;13:1677-1685.
29. van Deutekom JC, van Ommen GJ. Advances in Duchenne muscular dystrophy gene therapy. Nat Rev 2003;4:774-783.
30. Wilson RD, Davies G, Gagnon A, et al. Amended Canadian guideline for prenatal diagnosis (2005) change to 2005-techniques for prenatal diagnosis. J Obstet Gynaecol Can 2005;27:1048-1062.
31. Geifman-Holtzman O, Ober Berman J. Prenatal diagnosis: Update on invasive versus noninvasive fetal diagnostic testing from maternal blood. Expert Rev Mol Diagn 2008;8:727-751.
32. Liechti-Gallati S, Schneider V, Neeser D, Kraemer R. Two buffer PAGE system-based SSCP/HD analysis: A general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur J Hum Genet 1999;7:590-598.
33. Sitnik R, Campiotto S, Vainzof M, Pavanello RC, Takata RI, Zatz M, Passos-Bueno MR. Novel point mutations in the dystrophin gene. Hum Mutat 1997;10:217-222.
34. Muscarella LA, Piemontese MR, Barbano R, Fazio A, Guarnieri V, Quattrone A, Zelante L. Novel mutations of dystrophin gene in DMD patients detected by rapid scanning in biplex exons DHPLC analysis. Biomol Eng 2007;24:231-236.